KayoThera

Princeton, United States

KayoThera develops therapeutics used to cure late-stage and metastatic cancers.

$5.2M raised

Jul 2023

Series A

Biotechnology Health Care Medical

Top Investors

BioAdvanceAccelerator Life Science PartnersPier 70 VenturesNational Institute of General Medical ScienceWRF Capital

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about KayoThera

How much funding has KayoThera raised?

KayoThera has raised $5.2M in total funding. The most recent round was Series A. The last funding was announced in July 2023.

Who are KayoThera's investors?

KayoThera's investors include BioAdvance, Accelerator Life Science Partners, Pier 70 Ventures, National Institute of General Medical Science, WRF Capital.

Where is KayoThera headquartered?

KayoThera is headquartered in Princeton, United States.

What does KayoThera do?

KayoThera develops therapeutics used to cure late-stage and metastatic cancers.

What stage is KayoThera at?

KayoThera is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 19, 2023.

MLA

"KayoThera — Funding & Investors." VCBacked, July 19, 2023, https://www.vcbacked.co/company/kayothera. Accessed June 5, 2026.

APA

VCBacked. (2023). KayoThera — Funding & Investors. Retrieved June 5, 2026, from https://www.vcbacked.co/company/kayothera

Wikipedia (cite web)

{{cite web |title=KayoThera — Funding & Investors |url=https://www.vcbacked.co/company/kayothera |website=VCBacked |access-date=June 5, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 19, 2023.

Similar Companies in Biotechnology